Latin America Bispecific Antibodies Market Size & Outlook, 2025-2031
Latin America Bispecific Antibodies Market Size
According to Straits Research analysis, the Latin America Bispecific Antibodies Market was valued at USD 267.71 Million in 2024 and is projected to reach USD 712.72 Million by 2031, expanding at a CAGR of 15.8% during the forecast period. This growth is driven primarily by the healthcare and pharmaceutical industries, given bispecific antibodies' significant potential in cancer research and treatment. Other drivers include usage in sectors such as agriculture, chemicals and energy, primarily for bio-engineering applications. Emerging trends include the rise of green, low-carbon production methodologies and technological advancements in production processes. Moreover, the Latin American market possesses considerable export potential, particularly to developed Western markets seeking cost-effective solutions. Latin America is, therefore, strategically positioning itself as a competitive and innovative player in the global bispecific antibodies market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Latin America Bispecific Antibodies Market Highlights
- Within Type, Bi-specific T-cell engager accounted for the largest market size in 2024.
- During the forecast period, Bi-specific T-cell engager is anticipated to remain the highest-growth segment within the Type category.
- In 2024, Latin America accounted for 4.86% of the global bispecific antibodies market size.
- By 2031, United States is projected to lead the global market in terms of market size.
- Mexico is projected to emerge as the fastest-growing market in Latin America, reaching USD 46.97 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 267.71 Million |
| Market Size In 2031 | USD 712.72 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 15.8% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Latin America Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Latin America Bispecific Antibodies Market By Country 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Latin America Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Latin America Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Latin America Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
